We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Approves Teva's Generic OxyContin

Law360 (December 12, 2004, 12:00 AM EST) -- Federal regulators have granted tentative approval to a low-dose generic version Purdue Pharma LP's OxyContin pain reliever to Israeli drug maker Teva Pharmaceutical Industries Ltd.

Teva said the approval applies to 10-, 20- and 40-milligram extended release tablets of the oxycodone hydrochloride drug. The company previously received approval from the U.S. Food and Drug Administration for an 80-milligram version of OxyContin and began shipping that product on March 30.

Teva received 6 months exclusivity for the 80-milligram version of OxyContin and launched the product "at-risk," meaning...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.